CDC: 2012-2013 flu vaccine not as effective in elderly

CDC: 2012-2013 flu vaccine not as effective in elderly
Vaccination against influenza for the 2012/2013 flu season appears to be moderately effective in reducing the need for outpatient medical attention, but the effect is lower in the elderly, according to research published in the Feb. 22 issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report.

(HealthDay)—Vaccination against influenza for the 2012/2013 flu season appears to be moderately effective in reducing the need for outpatient medical attention, but the effect is lower in the elderly, according to research published in the Feb. 22 issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report.

Lisa Jackson, M.D., of the CDC in Atlanta, and colleagues analyzed data from the U.S. Influenza Vaccine Effectiveness Network to estimate vaccine effectiveness (VE) for the 2012/2013 influenza season.

The researchers estimated the overall VE against influenza A and B to be 47 and 67 percent, respectively, or 56 percent overall, which was close to the interim estimate of 62 percent. When stratified by age group, the estimates for VE against influenza A (H3N2) and B infections were mostly consistent across age groups, with the exception that lower VE against influenza A (H3N2) was seen among adults aged 65 and older. These findings suggest vaccination against influenza reduces the risk of illness requiring outpatient medical visits by one-half to two-thirds for most people, although VE was lower and not statistically significant among people aged 65 and older.

"Antiviral medications should be used as recommended for treatment of suspected influenza in certain patients, including those aged ≥65 years, regardless of their influenza vaccination status," the authors write.

More information: Full Text

add to favorites email to friend print save as pdf

Related Stories

CDC: Influenza activity increasing across the U.S.

Jan 05, 2013

(HealthDay)—Flu season descended on the United States early and hard this winter, with significant increases in flu activity observed over the past month, according to an update issued Jan. 4 by the U.S. ...

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

14 hours ago

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

14 hours ago

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

15 hours ago

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

15 hours ago

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments